According to our latest research, the global drug & gene delivery devices market size reached USD 187.6 billion in 2024, demonstrating robust expansion driven by technological advancements and increasing prevalence of chronic diseases. The industry is projected to grow at a CAGR of 9.2% from 2025 to 2033, positioning the market to attain a value of approximately USD 409.8 billion by 2033. The primary growth factor fueling this surge is the rising demand for targeted therapies and the continuous evolution of novel delivery systems that enhance the efficacy and safety of pharmaceutical and gene-based treatments.
https://growthmarketreports.co....m/report/drug-gene-d